Spinal myoclonus following intrathecal administration of diatrizoate meglumine
- PMID: 8903083
- DOI: 10.1111/jon199664256
Spinal myoclonus following intrathecal administration of diatrizoate meglumine
Abstract
Life-threatening myoclonus developed in a patient following inadvertent intrathecal usage of 60% diatrizoate meglumine. Rhabdomyolysis and myoglobinuria occurred. The patient was successfully treated with midazolam and vecuronium and complete recovery occurred.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
